Patient reported outcomes (PROs) of multiple myeloma (MM) patients from the PANORAMA-1 study who have received at least two prior regimens including bortezomib and an immunomodulatory agent
Patient reported outcomes (PROs) of multiple myeloma (MM) patients from the PANORAMA-1 study who have received at least two prior regimens including bortezomib and an immunomodulatory agent
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2016
Συγγραφείς:
Richardson, PG Hungria, V Yoon, SS Beksac, M Dimopoulos, MA Elghandour, A Jedrzejczak, WW Nakorn, TN Siritanaratkul, N Schlossman, R others
